Gastroenterology
Postoperative Ileus
0
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Postoperative Ileus is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
19
clinical trials
Completed16 · 84%
Unknown status2 · 11%
Recruiting1 · 5%
Clinical Trials
Trial Activity
19 trials
Alvimopan as a Rescue Treatment of Postoperative Ileus
Completed·—·Phase 4·NCT04405037·65 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)